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Abstract
Purpose The aim of this study was to perform a sys-
tematic review of studies concerning current treatment of
chondral defects of the knee.
Methods The relevance for evidence based data and for
successful surgical treatment of cartilage defects was
evaluated. From 56,098 evaluated studies, 133 studies
could be further pursued. These supplied data concerning
microfracturing, the osteochondral autograft transplanta-
tion system (OATS), the autologous chondrocyte implan-
tation (ACI) and the matrix induced chondrocyte
implantation (MACI). The modified Coleman Methodical
Score (CMS) and the Level of Evidence (LOE) were
applied to evaluate the quality.
Results In these studies, a total of 6,920 patients were
reviewed with a median of 32 patients per study and a mean
follow-up of 24 months. The mean CMS was 58 of 100
points. No study reached 100 points in the CMS. Three
studies reached a level above 90. Ten studies were Level I,
five studies reached Level II. Seven studies reached Level
III, 111 studies Level IV. MRI scans to verify the clinical
data were used by only 72 studies. The means in the mod-
ified CMS were for the different procedures as follows: ACI
58 points, MACI 57 points, microfracturing 68 points and
OATS 50 points. 24 studies applied the Lysholm Score (LS)
for clinical evaluation of cartilage surgery. All operative
procedures yielded comparable improvements of the LS
(n.s.) meaning that no operative procedure proved superior.
Conclusion As the majority of studies evaluated by this
review is insufficient for EBM purposes more coherent
studies with LOE of I or II are needed. Co-relating the
systems of CMS and LOE and validating the applied scores
seems desirable.
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Introduction
Articular chondral defects find an increasing interest of
orthopaedic surgeons because these lesions normally do not
heal spontaneously and may predispose the joint to the
development of secondary osteoarthritis.
This study was conducted to evaluate if any of today’s
most frequently applied and well documented articular
resurfacing methods are evidence based. It is important for
the funding health system to have objective criteria about
the effectiveness of the respective methods as most deci-
sions on funding are based on reliable data.
A number of different treatment options exist, none of
which may be judged as the golden standard. Microfrac-
turing, Osteochondral Autograft Transplantation System
(OATS), Autologous Chondrocyte Transplantation (ACT)
and Matrix Induced Chondrocyte Implantation (MACI) are
the operative procedures for the treatment of articular
defects which are very well documented by studies in the
literature.There is much controversy to be found as to
which treatment would be the most effective.
The multitude of studies treating this topic, the diversity
of study designs and the high number of articles published
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are a reason for a comprehensive review with a systematic
analysis. Some systematic reviews have been done on
related subjects [59, 101].
Evidence Based Medicine (EBM) examines, evaluates
and improves the quality of published data. It aims at
creating scientifically sound standards for the physician.
Important is the level of evidence with Level I and II
studies yielding sufficient data from prospective random-
ised studies.
With articular resurfacing by the treatment of cartilage
defects becoming increasingly popular and the public
health system demanding evidence based facts especially
for the different operative procedures existing in this
field, a systematic review evaluating the existing mate-
rial on the basis of evidence based medicine seems
desirable.
Materials and methods
We performed a search strategy that involved clinical trials
only. These should evaluate the treatment of cartilage
defects in the human knee performing microfracturing,
OATS, ACT and MACI, being currently the most com-
monly applied surgical techniques. A publication period
from 2002 to 2007 was selected. The MEDLINE, EM-
BASE and Evidence Based Medicine Reviews were our
databases. To extract the relevant articles, a search machine
in the Ovid Linksolver was established. Online accessi-
bility was one inclusion criterium. The other one was a text
written in English, French or German. Abstracts in one of
these languages were also included where the full paper
was only available in a different language not meeting the
selection criteria.
A total of 56,098 abstracts was screened by two inde-
pendent scientists, 179 relevant publications could be
selected by both. Of these, 133 studies could be extracted
that met the following criteria: evaluating exclusively the
operative techniques microfracturing, OATS, ACT and
MACI, published between 2002 and 2007, available in the
above databases, being online accessible, language in
English, French or German, suitability for EBM evaluation.
Only papers evaluating the above operative procedures
without any additional procedures werde considered as any
additional procedure would influence the Level of
Evidence.
Coleman Methodical Score (CMS)
The CMS as introduced first by Coleman et al. [21] was
originally applied for grading clinical studies on patellar
and Achilles tendinopathy. It was modified by Jakobsen
et al. [59] changing the category of the postoperative
rehabilitation protocol. The score has two parts and 10
criteria. A maximum score is 100 points, the minimum 0. A
score of 100 means that the study excludes almost any bias,
coincidence and other influences. Higher scores may sup-
port EBM.
Level of evidence (LOE) and lysholm score (LS)
The studies were also assessed by the use of the level-of-
evidence-rating applied in the American Volume of The
Journal of Bone and Joint Surgery since 2003. The Lys-
holm Score (LS) applied for cartilage injuries scores stair
climbing, instability, squatting, limp, pain, support, locking
and swelling. It was applied in 24 studies to compare
clinical outcome of the different operative procedures as
reflected in the studies.
Statistical methods
SSPS software version for Windows, version 17.0 (SSPS
Inc, Chicago, Illinois) was applied to analyze the data. The
continuous variables were reflected as medians. They were
tested with the Shapiro-Wilkes-Test for their normal dis-
tribution. The Pearson correlation was used for normally
distributed data. The Kruksal-Wallis-Test was used to test
if the outcomes of different kinds of therapy differed
significantly.
Results
56,098 articles corresponding to a MEDLINE, EMBASE
and Evidence Based Medicine Reviews search conducted
for the years 2002–2007 were reviewed.
133 relevant studies could be extracted. These
reviewed 6,920 patients with a median of 32 patients per
study and a mean follow-up of 24 months. There was an
increase of 11% in the number of studies from 2002 to
2007 (Fig. 1). The most frequently described procedures
in the single studies were ACI (36%), OATS (30%),
MACI (14%) and microfracturing (10%). The combined
studies compared ACI and OATS (4%), OATS and
microfracturing (3%), MACI and microfracturing (1%),
ACI and microfracturing (1%), ACI and MACI (1%)
(Fig. 2).
Ten publications reached a LOA of I, five studies
reached Level II. Seven studies reached Level III, 111
studies Level IV (Fig. 3).
The CMS as modified by Jakobsen et al. [59] yielded
only ten studies with a score of 80 or above (Fig. 4). No
study reached a score of 100. Three studies reached a score
above 90. The mean CMS of all studies was 58 points.
Applied to the operative techniques, microfraturing
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reached the highest modified CMS (mean = 68), followed
by ACI (mean = 58), MACI (mean = 57) and OATS
(mean = 50) (Table 1). To evaluate the operative results,
24 studies applied the Lysholm Score (LS) for cartilage
injury. An increase in the LS is related to the success of the
procedure. The MACI reached the highest increase with a
Fig. 1 The number of studies in
relation to the years from 2002
to 2007. An increase of 11%
was noted
Fig. 2 Number of studies
evaluating OATS, MACI,
Microfracturing, ACI and a
combination of procedures
Fig. 3 Number of studies
grouped by their level of
evidence
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median of 34 points, followed by OATS [32], microfrac-
turing [32] and ACI [31]. There was no significant differ-
ence in the outcome of the procedures (n.s.) in the
ONEWAY ANOVA).
Relating the studies applying the LS with their CMS
yields a low correlation coefficient (r = 0.129) with high
significance in the matched pair t-test (P \ 0.001). MRI
scans to verify the clinical data were applied in only 72
studies.
Discussion
The most important finding in this study was the following:
although numerous studies examine results after cartilage
surgery, no evidence based results could be clearly defined.
The treatment of cartilage lesions is a problem in ortho-
paedic surgery as the self limiting of these lesions is not
possible. Risks for developing a secondary arthritis are
considerable, and for this reason the chondral lesions
should be addressed. We have found that the general
research about chondral lesions has increased by 11% from
2002 to 2007 which is not surprising giving the importance
of this matter and its possible effects on lifestyle and
activity. In order to help funding organisations such as
insurance companies and public health systems to answer
the following question: Is it possible to deduct from these
studies the optimal treatment for the optimal patient? And
is the Level of Evidence sufficient to underline this
deduction?
The recommendation of the National Institute for Health
and Clinical Excellence in London (NIHCE) from 2005 is
based on four prospective randomised studies. Two compared
ACI and OATS [11, 55], one compared ACI and microfrac-
turing [67] and one compared different ways of ACI [13].
These studies demonstrated inconsistent and partially
contradictory results which lead to discontinuation of
funding of ACI by the British National Health System
(NHS). This example shows the importance of Level I/II
studies influencing public funding of a method.
Concerning the OATS technique, only 1 randomised
controlled study by Bentley et al. [11] and the Level IV
study by Hangody and Fu¨les [47] were considered by the
NIHCE as supportive in 2006. The Level I/II studies by
Horas et al. [55] and Dozin et al. [25] were not considered.
Studies comparing OATS and microfracturing like the
prospective randomized one from Gudas et al. [39] were
also not considered. More awareness should be raised to
the funding boards about existing studies. This may be the
future task of the respective medical boards.
One of the few studies comparing costs of articular
resurfacing, Derrett et al. [23] reach the conclusion that
average costs for ACI were lower than mosaicplasty. They
recommend, however, more prospective studies to confirm
this matter.
Generally, the MACI has a particulary poor data base:
from 2002 to 2007, only one Level I study was found [8]. A
prospective randomised study by Basad et al. [9] improves
the data on MACI by comparing MACI to microfracturing.
Again, a difficult interpretation of the results due to
different scores applied and partial incompatibility were
noted, demonstrating that even Level I studies are difficult
to compare and that the thorough review of the existing
evidence based literature is important, even more so
because these studies are comparatively scarce. The vari-
ance of the clinical tests applied is considerable: in the
Fig. 4 The modified Coleman
methodological score score as
reached by number of studies
Table 1 Modified Coleman methodical score applied to the indi-
vidual operative procedures
Type of therapy Mean SD Median Minimum Maximum N
ACI 58 18 60 20 97 56
MACI 57 18 63 20 84 21
Microfracture 68 22 73 14 97 20
OATS 50 19 52 10 85 49
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analyzed 133 studies, 27 different clinical scores were
applied impairing comparability.
A common flaw in many studies is the selection bias
with drop outs being neglected. The variety of clinical
scores applied makes the studies difficult to compare. The
Lysholm score for example is applied in only 24 studies.
Even in these cases, it is not decided which operative
method is preferable. This diversity of applied scores
makes it difficult to refer the outcomes to certain operative
methods, often impairing the decision making by the
funding organisations.
No study reached a CMS of 100, the average CMS was
58. This underlines the fact that most studies do not
completely meet the criteria set by Coleman et al. [21] and
Jakobsen [59].
Either these criteria are too strict to be applied for EBM
in cartilage resurfing procedures or there are indeed too few
studies that meet the criteria for EBM. The authors feel that
the latter is more likely as the few studies reaching a higher
CMS reach high LOEs.
The relationship between CMS and LOE has to the
authors knowledge not yet been clearly established. It may
be accepted that a CMS of 100 would support the highest
LOE, and that a higher CMS would also support a high
LOE. Our analysis looks at LOE and CMS as two different
entities to evaluate the clinical significance of the screened
studies. Not established is also the number of studies
necessary to reach a strong EBM classification. For
example, it remains uncertain if one study with a CMS of
100 and a LOE of I would suffice to support that the
method is evidence based. This may be a serious flaw to the
system of EBM. We could show in this study that decisions
by health authorities and funding organisations are based
on few EBM relevant studies, if at all. It is desirable that
more prospective randomised studies are performed with
comparable scores. This conclusion is supported by an
article by Mithoefer et al. [101], where a similar conclusion
regarding microfraturing alone is reached. We found that
those studies applying the Lysholm Score for cartilage
injuries could not provide a decision on a preferential
method. There was also no co-relation between a higher
Lysholm Score and the quality of a study, a fact also found
by Jakobsen et al. [59]. Our results confirm that choosing
and applying a commonly used score does not necessarily
lead to a higher standard of EBM.
The studies researched in this review are quite heter-
ogenous. For example, ACI is performed with a multitude
of matrices and membranes, varying the original method.
The OATS technique also varies quite considerably, in
method and in definition. Even microfracturing as first
introduced by Steadman is modified in many ways, using
various membranes and matrices. It seems impossible to
single out every factor that may influence the outcome of
the respective research. In order to gain reliable EBM
based data the methods of future studies should be coor-
dinated and unified, preferably as suggested by their first
author and his group, and performed by multi center
research. As this is already standard for pharmaceutical
research, the authors see no reason why this may not be
applied in cartilage surgery.
Conclusion
There seems to be generally low methodical quality in the
studies evaluated in this analysis. This may indicate that
some caution is required when interpreting study results
after surgical cartilage repair.
Definitive recommendations on which procedure to
choose may not be given on the basis of the studies eval-
uated in this study. More attention should be paid to
methodical quality when designing, performing, and
reporting clinical studies. It is difficult to recommend a
certain operative procedure because the pertaining litera-
ture is contradictory, prospective randomised trials are
scarce in overall relation to the published literature and the
applied scores are mostly unvalidated, too diverse and
difficult to compare. This should change as decisions on
funding by the public health system and the insurance
companies tend to rely on prospective randomised studies.
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